Visit the drug pipeline 
Skip Navigation Links
About Psoriasis
Types of Psoriasis
Specific Locations
Causes of Psoriasis
Pregnancy
Treatments
Topicals
Light Therapy
Systemics
FDA Determinations
Treatments
Related Conditions
Science of Psoriasis
Resources


Questions? Ask a health educator

Download educational booklets

Conception & pregnancy

FDA determinations

The following table shows FDA-approved psoriasis treatments and their category for use by pregnant and nursing women.

Generic name Brand name FDA category Comments
Acitretin Soriatane X

Causes birth defects. Absolutely avoid.

Adalimumab Humira B

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

Alefacept Amevive B

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

Anthralin   C

No clear evidence of birth defects. Avoid unless necessary.

Calcipotriene Dovonex C

No clear evidence of birth defects. Avoid unless necessary.

Calcipotriene
and
betamethasone
dipropionate
Taclonex C

No clear evidence of birth defects. Avoid unless necessary.

Calcitriol Vectical ointment C

No clear evidence of birth defects. Avoid unless necessary.

Cyclosporine   C

No clear evidence of birth defects. Avoid unless necessary.

Efalizumab Raptiva C

No clear evidence of birth defects. Avoid unless necessary. On April 8, 2009, Genentech, Inc. announced a voluntary withdrawal of Raptiva from the U.S. Market, this drug is no longer available. Please contact your dermatologist for further information.

Etanercept Enbrel B

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

Infliximab Remicade B

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

Methotrexate   X

Even small doses can cause defects in first trimester. Absolutely avoid.

PUVA   C

No clear evidence of birth defects, although PUVA affects DNA. Avoid unless necessary.

Tazarotene Tazorac X

Risk of internal absorption. Absolutely avoid.

Topical steroids   C

No clear evidence of birth defects. Avoid unless necessary.

UVB  

Safe during pregnancy. May cause skin discoloration.

Key to FDA categories

B

Studies with animals have not found risk to the fetus but no studies have been done in humans.

C Safety is not substantiated by animal or human studies.
X Risk in pregnancy outweighs any benefits

Copyright © 1996-2013 National Psoriasis Foundation/USA

Any duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of National Psoriasis Foundation. National Psoriasis Foundation does not endorse or accept any responsibility for the content of external websites.

National Psoriasis Foundation | 6600 SW 92nd Ave., Suite 300, Portland, OR 97223
getinfo@psoraisis.org | www.psoriasis.org